跳至主要内容
临床试验/CTRI/2025/05/086155
CTRI/2025/05/086155尚未招募不适用

Correlation of GBRADS USG scoring system with histopathology

Tata Memorial Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年5月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1
主要终点
Accuracy of GBRADS in predicting the final histopathology findings.

研究概览

简要总结

India has one the highest incidences of Gallbladder Cancer (GBC) in the world, as per registry and GLOBOCAN data. Advanced GBC has a poor prognosis hence early diagnosis and management are crucial. Ultrasound/ Sonography is often the first imaging test to evaluate patients with suspected gallbladder diseases. Gallbladder wall thickening (GWT) is a common finding at ultrasound. It is nonspecific and represents both benign and malignant diseases.

The importance of wall thickening as a sign of gallbladder cancer is often missed during preoperative evaluations. This can lead to finding gallbladder cancer by chance or, worse, to more advanced disease and poorer outcomes. This study looks at past data to find out how well the GB-RADS scoring system works in identifying whether gallbladder conditions are malignant or benign.

The Gall Bladder Reporting and Data System (GBRADS) is ultrasound risk stratification reporting tool proposed to improve consistency in ultrasound interpretations, reporting and assessment of risk of malignancy in gallbladder wall thickening.

In this study we will evaluate the correlation between the GBRADS ultrasound scoring system and histopathological findings in order to determine the accuracy of GBRADS scores in predicting malignancy and benign conditions of gall bladder.

In this study we will enroll any patients with suspected gallbladder pathology who have undergone ultrasound imaging followed by histopathological examination (either a biopsy or a surgery) only patients with metastatic disease at presentation will be excluded.

A total pf 150 participants will be collected in this study. This is a retrospective study only data collection will be done. In this study patients underwent ultrasound and scored via GBRADS for any suspected gall bladder pathology and histopathological examination from 1st of February 2023 will be enrolled into the study.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Inclusion: Any patients with suspected gallbladder pathology who have undergone ultrasound imaging followed by histopathological examination (either a biopsy or a surgery).

排除标准

  • All patients with metastatic disease at presentation.

结局指标

主要结局

Accuracy of GBRADS in predicting the final histopathology findings.

时间窗: After completion of data collection- 1yr

次要结局

未报告次要终点

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验